Getting people vaccinated can be a public health challenge. Getting them to come back for a second dose at the right time can be even more difficult. This week we highlight why people may be skipping their second COVID-19 dose and how challenging getting that second dose can be even for people motivated ... READ MORE >
Health care
5 things to know in life sciences: Week of April 19
This week we look at comments from acting Food and Drug Administration commissioner Janet Woodcock on perceptions that the agency is getting tougher on drug companies during the approval process. We also highlight new uses of CRISPR to control gene expression, venture funds focused on life sciences, newly ... READ MORE >
5 things to know in life sciences: Week of April 12
For the past few months, we've shared stories of positive developments in the race for COVID-19 vaccines and vaccinations. This week, we look at the long backstory of the challenges that have haunted the AstraZeneca vaccine efforts and why it is so critical for the world that these issues are resolved. We ... READ MORE >
5 things to know in life sciences: Week of April 5
As the months of 2021 tick by, the percentage of Americans vaccinated is rapidly increasing. This offers the hope of a return to more normal life but also raises new questions, including whether companies can mandate vaccines or how we track the virus. We also look at the lack of diversity on the boards ... READ MORE >
CHART OF THE DAY: Broadband expansion is the bridge to better health
Today is World Health Day. The World Health Organization's theme this year, “a fairer, healthier world,” could not be more timely for the United States. President Biden recently released a $2.2 trillion infrastructure plan, which includes a number of initiatives directly or indirectly related to health ... READ MORE >
5 things to know in life sciences: Week of March 29
Each week, we highlight five things you need to know about in the life sciences industry. Here’s the latest. 1. FTC challenges biopharma merger as antitrust scrutiny grows Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the ... READ MORE >
5 things to know in life sciences: Week of March 22
In this week’s life sciences roundup: the AstraZeneca-Oxford COVID-19 vaccine has faced challenging headwinds in the past week as several European Union countries paused distribution pending additional information from the European Medicines Agency, and as the National Institute of Allergy and Infectious ... READ MORE >
5 things to know in life sciences: Week of March 15
The Federal Trade Commission’s new acting chair, Rebecca Kelly Slaughter, has initiated a review of the agency's processes for approving pharma mergers. This is expected to result in a tougher road for these mergers, as we explain below. We also look at the top drugs losing their exclusivity this year, ... READ MORE >
An evolution of the economy: Living, and adapting, with COVID-19
Over the past year, leaders around the globe have held their breath as the pandemic unfolded and drastic measures were tested, from safety mitigation and scientific developments to unprecedented fiscal stimulus. And now, as we emerge from the cloud of 2020, it is likely the current pandemic will soon pass ... READ MORE >
Understanding the rapid spread of COVID-19 variants
As of March 12, more than 341 million doses of COVID-19 vaccines have been administered globally at a remarkable pace of 8.5 million doses a day, according to Bloomberg. Nearly a third of those vaccinations have occurred in the United States, where we have already administered more than 101 million doses ... READ MORE >